Document:

Employee Stock Purchase Plan, as amended

 EXHIBIT 10.10 
 GENTIVA HEALTH SERVICES, INC. 
 EMPLOYEE STOCK PURCHASE PLAN 
 (amended as of November 8, 2007) 
  

	1.	Purpose. 

 The purpose of this Plan is to provide
eligible employees the opportunity to purchase Gentiva Health Services, Inc. Common Stock on a basis that qualifies for the tax treatment prescribed by Section 423 of the Code. 
  

	2.	Definitions. 

 The following terms, when used in the
Plan, shall have the following meanings: 
  

	 	(a)	“Board” or “Board of Directors” means the Board of Directors of the Company, as constituted from time to time. 

  

	 	(b)	“Code” means the Internal Revenue Code of 1986, as amended from time to time. References to a particular section of the Code include any successor provisions.

  

	 	(c)	“Committee” means the committee appointed by the Board of Directors to administer the Plan pursuant to the provisions of Section 3(a) below. 

 

	 	(d)	“Common Stock” means common stock, par value $.10 per share, of the Company. 

  

	 	(e)	“Company” means Gentiva Health Services, Inc., a Delaware corporation. 

  

	 	(f)	“Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time. 

  

	 	(g)	“Fair Market Value” on a particular date means the mean between the highest and lowest sales prices of a share of Common Stock on the principal stock exchange or stock
market on which the Common Stock may be listed or admitted to trading. If there were no sales on such date, the respective prices on the most recent prior day on which sales were reported shall be used. If the foregoing method of determining fair
market value should be inconsistent with Section 423 of the Code, “Fair Market Value” shall be determined by the Committee in a manner consistent with Section 423 of the Code and shall mean the value as so determined.

  

	 	(h)	“Offering” means a period, designated by the Committee in accordance with the provisions of Section 6 of the Plan, on the first day of which options will be granted
to eligible employees pursuant to Section 8(a) of the Plan and on the last day of which such options will be deemed exercised or will expire, as applicable, in accordance with Section 8(b) of the Plan. 

  

	 	(i)	“Participant” or “Participating Employee” means an employee of the Company or a Participating Subsidiary who is eligible to participate in an Offering under the
Plan pursuant to Section 5 below and who elects to participate in such Offering in accordance with Section 6 below. 

	 	(j)	“Participating Subsidiary” means, with respect to an Offering under the Plan, a Subsidiary the employees of which are authorized by the Committee as provided in
Section 5 below to participate in such Offering. 

  

	 	(k)	“Plan” means the Gentiva Health Services, Inc. Employee Stock Purchase Plan set forth herein, as amended from time to time. 

  

	 	(l)	“Parent” means a parent corporation as defined in Section 424(e) of the Code, including a corporation which becomes such a parent in the future.

  

	 	(m)	“Subsidiary” means a subsidiary corporation as defined in Section 424 (f) of the Code, including a corporation which becomes such a subsidiary in the future.

  

	 	(n)	“Total Compensation” means, with respect to any Offering, all remuneration, as defined in Section 3401(a) of the Code (for purposes of income tax withholding at the
source), but determined without regard to any rules that limit remuneration included in wages based on the nature and location of employment or the services performed, for services paid to an employee during, or coincident with the end of, such
Offering; provided, however, that “Total Compensation” shall not include the following items (even if includable in gross income): (1) reimbursement or other expense allowances; (2) fringe benefits (cash and non cash);
(3) moving expenses and gross up for taxes; (4) welfare benefits (including disability income from insurance policies); (5) payments on account of severance of the employee from employment; (6) payments on account of early
retirement of the employee; (7) income arising from the grant or exercise of stock options; (8) restricted stock awards; and (9) distributions under this Plan. 

  

	3.	Administration. 

  

	 	(a)	The Plan shall be administered by a committee of the Board consisting of two or more directors appointed from time to time by the Board. 

  

	 	(b)	Subject to the provisions of the Plan, the powers of the Committee shall include having the authority, in its discretion, to: 

  

	 	(i)	define, prescribe, amend and rescind rules, regulations, procedures, terms and conditions relating to the Plan; and 

  

	 	(ii)	interpret, administer and construe the Plan and make all other determinations necessary or advisable for the administration of the Plan, including but not limited to correcting
defects, reconciling inconsistencies and resolving ambiguities. 

  

	 	(c)	The interpretation by the Committee of the terms and conditions of the Plan, and its administration of the Plan, and all action taken by the Committee, shall be final, binding and
conclusive on the Company, its stockholders, Subsidiaries, all Participants and employees, and upon their respective successors and assigns, and upon all other persons claiming under or through any of them. 

  

	 	(d)	Members of the Board, members of the Committee and persons to whom authority is delegated under Section 3(e) below acting under this Plan shall be fully protected in relying in
good faith upon the advice of counsel and shall incur no liability except for gross or willful misconduct in the performance of their duties. 

  

 2 

	 	(e)	The Committee may delegate its authority to administer the Plan to any individuals as the Committee may determine and such individuals shall serve solely at the pleasure of the
Committee. Any individuals who are authorized by the Committee to administer the Plan shall have the full power to act on behalf of the Committee, but shall at all times be subordinate to the Committee and the Committee shall retain ultimate
authority for the administration of the Plan. 

  

	4.	Stock Subject to the Plan. 

  

	 	(a)	Subject to paragraph (c) below, as of the initial adoption of the Plan, the aggregate number of shares of Common Stock which may be sold under the Plan is 1,200,000 shares of
Common Stock. Effective as of February 24, 2005, (but subject to shareholder approval within 12 months of that date), an additional 1,200,000 shares of Common Stock may be sold under the Plan, such that the aggregate number of shares of Common
Stock which may be sold under the Plan is increased to 2,400,000 shares. 

  

	 	(b)	If the number of shares of Common Stock that Participating Employees become entitled to purchase is greater than the number of shares of Common Stock that are offered in a
particular Offering or that remain available under the Plan, the available shares of Common Stock shall be allocated by the Committee among such Participating Employees in such manner as it deems fair and equitable. 

  

	 	(c)	In the event of any change in the Common Stock, through recapitalization, merger, consolidation, stock dividend or split, combination or exchange of shares, spin-off or otherwise,
the Committee may make such equitable adjustments in the Plan and the then outstanding Offerings as it deems necessary and appropriate including, but not limited to, changing the number of shares of Common Stock reserved under the Plan, and the
purchase price of shares in the current Offering; provided that any such adjustments shall be consistent with Sections 423 and 424 of the Code. 

  

	 	(d)	Shares of Common Stock which are to be delivered under the Plan may be obtained by the Company from its treasury, by purchasing such shares on the open market or from private
sources, or by issuing authorized but unissued shares of its Common Stock. Shares of authorized but unissued Common Stock may not be delivered under the Plan if the purchase price thereof is less than the par value (if any) of the Common Stock at
the time. The Committee may (but need not) provide at any time or from time to time (including without limitation upon or in contemplation of a change in control) for a number of shares of Common Stock equal in number to the number of shares then
subject to options under this Plan to be issued or transferred to, or acquired by, a trust (including but not limited to a grantor trust) for the purpose of satisfying the Company’s obligations under such options, and, unless prohibited by
applicable law, such shares held in trust shall be considered authorized and issued shares with full dividend and voting rights, notwithstanding that the options to which such shares relate might not be exercisable at the time.

  

 3 

	5.	Eligibility. 

 All employees of the Company and any
Subsidiaries designated by the Committee from time to time will be eligible to participate in the Plan, in accordance with and subject to such rules and regulations as the Committee may prescribe; provided, however, that: 
  

	 	(a)	such rules shall comply with the requirements of the Code (including but not limited to Section 423(b)(3), (4) and (8) thereof); 

  

	 	(b)	the Committee may (but need not) in its discretion exclude employees who have been employed by the Company or a Participating Subsidiary less than two years and/or highly
compensated employees within the meaning of Section 414(q) of the Code from being eligible to participate in the Plan or any Offering, but unless and until otherwise determined by the Committee, no employees will be excluded pursuant to this
Section 5(b); 

  

	 	(c)	no employee may be granted an option under the Plan if such employee, immediately after the option is granted, owns stock possessing 5% or more of the total combined voting power or
value of all classes of stock of his employer corporation or any Parent or Subsidiary (with the rules of Section 424(d) of the Code applicable in determining the stock ownership of an employee, and stock which the employee may purchase under
outstanding options, whether or not such options qualify for the special tax treatment afforded by Section 421(a) of the Code, shall be treated as stock owned by the employee); and 

  

	 	(d)	all Participating Employees shall have the same rights and privileges except as otherwise permitted by Section 423(b)(5) of the Code. 

  

	6.	Offerings; Participation. 

 The Company may make
Offerings of up to 27 months’ duration each, to eligible employees to purchase shares of Common Stock under the Plan, until all shares authorized to be delivered under the Plan have been exhausted or until the Plan is sooner terminated by the
Board. Subject to the preceding sentence, the number, commencement date and duration of any Offerings shall be determined by the Committee in its sole discretion; provided that, unless the Committee determines otherwise, (a) the first Offering
shall commence on February 1, 2000 and shall terminate on June 30, 2000, and (b) a new six-month Offering shall commence immediately after the end of the previous Offering. The duration of any Offering need not be the same as the
duration of any other Offering, and more than one Offering may commence or terminate on the same date if the Committee so provides. Subject to such rules and procedures as the Committee may prescribe, an eligible employee may elect to participate in
an Offering at such time(s) as the Committee may permit by authorizing a payroll deduction for such purpose in one percent increments of up to a maximum of ten percent of his or her Total Compensation with respect to such Offering or such lesser
amount as the Committee may prescribe. Participant elections may be made in any manner deemed appropriate by the Committee from time to time, including by voice response or through the internet. The Committee may (but need not) permit employee
contributions to be made by means other than payroll deductions, provided that in no event shall an employee’s contributions (excluding interest, if any, credited pursuant to Section 7(a) below) from all sources in any Offering exceed ten
percent of his or her Total Compensation with respect to such Offering or such lesser amount as the Committee may prescribe. The Committee may at any time suspend or accelerate the completion of an Offering if required by law or deemed by the
Committee to be in the best interests of the Company, including in the event of a change in ownership or control of the Company or any Subsidiary. 
  

 4 

	7.	Payroll Deductions. 

  

	 	(a)	The Company will maintain payroll deduction accounts on its books for all Participating Employees, and may (but need not) credit such accounts with interest if (and only if) the
Committee so directs at such rate (if any) as the Committee may prescribe. All employee contributions and any interest thereon which the Committee may authorize in accordance with the preceding sentence shall be credited to such accounts. Employee
contributions and any interest credited to the payroll deduction accounts of Participating Employees need not be segregated from other corporate funds and may be used for any corporate purpose. 

  

	 	(b)	At such times as the Committee may permit and subject to such rules and procedures as the Committee may prescribe, a Participating Employee may suspend his or her payroll deduction
during an Offering, or may withdraw the balance of his or her payroll deduction account and thereby withdraw from participation in an Offering. 

  

	 	(c)	Any balance remaining in an employee’s payroll deduction account after shares have been purchased in an Offering pursuant to Section 8(b) below will be refunded to the
Participating Employee. Upon termination of the Plan, all amounts in the accounts of Participating Employees shall be carried forward into their payroll deduction accounts under a successor plan, if any, or refunded to them, as the Committee may
decide. 

  

	 	(d)	In the event of the termination of a Participating Employee’s employment for any reason, his or her participation in any Offering under the Plan shall cease, no further amounts
shall be deducted pursuant to the Plan and the balance in the employee’s account shall be paid as soon as practicable following such termination of employment to the employee, or, in the event of the employee’s death, to the
employee’s estate. 

  

	8.	Purchase; Limitations. 

  

	 	(a)	Subject to Section 5 above and within the limitations of Section 8(d) below, each person who is an eligible employee of the Company or a Participating Subsidiary on the
first day of an Offering under the Plan is hereby granted an option, on the first day of such Offering, to purchase a number of whole and/or partial shares of Common Stock at the end of such Offering determined by dividing ten percent (or such
lesser percentage as may be specified by the Committee as the maximum employee contribution percentage in such Offering) of such employee’s Total Compensation with respect to such Offering, plus such interest (if any) as the Committee may
authorize to be credited during such Offering in accordance with Section 7(a) above, by 85 percent of the Fair Market Value of a share of Common Stock on the last date of such Offering(or such other Fair Market Value as the Committee may have
specified in advance of such Offering), provided that in no event shall the number of shares of Common Stock that may be purchased under any such option exceed 5,000 shares or such higher or lower number of whole or partial shares as the Committee
may have specified in advance of such Offering as the maximum amount of stock which may be purchased by an employee in such Offering. The purchase price of such shares under such options shall be determined in accordance with Section 8(c)
below. The Company’s obligation to sell and deliver Common Stock in any Offering or pursuant to any such option shall be subject to the approval of any governmental authority whose approval the Committee determines it is necessary or advisable
to obtain in connection with the authorization, issuance, offer or sale of such Common Stock. 

  

 5 

	 	(b)	As of the last day of the Offering, the payroll deduction account of each Participating Employee shall be totaled. Subject to the provisions of Section 7(b) above and 8(d)
below, if such account contains sufficient funds as of that date to purchase one or more whole or partial shares of Common Stock at the price determined under Section 8(c) below, the Participating Employee shall be conclusively deemed to have
exercised the option granted pursuant to Section 8(a) above for as many whole or partial shares of Common Stock as the amount of his or her payroll deduction account (including any contributions made by means other than payroll deductions and
including any interest credited to the account) at the end of the Offering can purchase (but in no event for more than the total number of shares that are subject to the option); such employee’s account will be charged for the amount of the
purchase and for all purposes under the Plan the employee will be deemed to have acquired the shares on that date; and either a stock certificate representing such shares will be issued to him or her, or the Company’s record keeper will make an
entry on its books and records evidencing that such shares have been duly issued or transferred as of that date, as the Committee may direct. Notwithstanding any provision of the Plan to the contrary, unless otherwise determined by the Committee,
fractional shares may be purchased under the Plan. Any option granted pursuant to Section 8(a) above which is not deemed exercised as of the last day of the Offering in accordance with the foregoing provisions of this Section 8(b) shall
expire on that date. 

  

	 	(c)	Unless the Committee determines before the first day of an Offering that a different price that complies with Section 423 of the Code shall apply, the price at which shares of
Common Stock may be purchased under each option granted pursuant to Section 8(a) above shall be an amount equal to 85 percent of the Fair Market Value of the Common Stock at the time such option is exercised. 

  

	 	(d)	In addition to any other limitations set forth in the Plan, no employee may be granted an option under the Plan which permits his or her rights to purchase stock under the Plan, and
any other stock purchase plan of his or her employer corporation and its Parent and Subsidiary that is qualified under Section 423 of the Code, to accrue at a rate which exceeds $25,000 of the Fair Market Value of such stock (determined at the
time such option is granted) for each calendar year in which the option is outstanding at any time. The Committee may further limit the amount of Common Stock which may be purchased by any employee during an Offering in accordance with
Section 423(b)(5) of the Code. 

  

	9.	No Transfer. 

  

	 	(a)	No option, right or benefit under the Plan may be transferred by any employee, whether by will, the laws of descent and distribution, or otherwise, and all options, rights and
benefits under the Plan may be exercised during an employee’s lifetime only by such employee. 

  

	 	(b)	Book entry accounts and certificates for shares of Common Stock purchased under the Plan may be maintained or registered, as the case may be, only in the name of the Participating
Employee or, if such employee so indicates in accordance with the procedures prescribed by the Committee, , in his or her name jointly with a member of his or her family, with right of survivorship. 

  

	10.	Effective Date and Duration of Plan. 

 The Plan
shall become effective when adopted by the Board, provided that the stockholders of the Company approve it within 12 months thereafter. If not so approved by shareholders, the Plan shall be 

  

 6 

 
null, void and of no force or effect. If so approved, the Plan shall remain in effect until all shares authorized to be issued or transferred hereunder have
been exhausted or until the Plan is sooner terminated by the Board of Directors, and may continue in effect thereafter with respect to any options outstanding at the time of such termination if the Board of Directors so provides. 
  

	11.	Amendment and Termination of the Plan. 

 The Plan
may be amended by the Board of Directors, without shareholder approval, at any time and in any respect, unless shareholder approval of the amendment in question is required under Section 423 of the Code. The Plan may also be terminated at any
time by the Board of Directors. 
  

	12.	General Provisions. 

  

	 	(a)	Nothing contained in this Plan shall be deemed to confer upon any person any right to continue as an employee of or to be associated in any other way with the Company for any period
of time or at any particular rate of compensation. 

  

	 	(b)	No person shall have any rights as a stockholder of the Company with respect to any shares optioned under the Plan until such shares are issued or transferred to him or her.

  

	 	(c)	All expenses of adopting and administering the Plan shall be borne by the Company, and none of such expenses shall be charged to any employee. 

  

	 	(d)	The Plan shall be governed by and construed under the laws of the State of New York, without giving effect to the principles of conflicts of laws of that State.

  

	 	(e)	The Plan and each Offering under the Plan is intended to qualify as an “employee stock purchase plan” within the meaning of Section 423 of the Code. Transactions
under the Plan by or with respect to persons subject to Section 16(b) of the Exchange Act with respect to transactions involving equity securities of the Company are also intended to qualify for exemption under SEC Rule 16b-3, unless the
Committee specifically determines otherwise. Every provision of the Plan shall be administered, interpreted and construed to carry out those intentions. 

  

 7Form of Severance Agreement

 EXHIBIT 10.14 
                     , 200     
                                      
                                      
                                      
 Dear             : 
 In consideration of the mutual promises, covenants and obligations contained herein, this letter agreement (the “Letter Agreement”) amends and restates the letter agreement between you and Gentiva Health
Services, Inc. (the “Company”) dated [                    ] (the “Original Letter Agreement”), which is superseded in its
entirety by this Letter Agreement. This amendment and restatement of the Original Letter Agreement is intended to bring it into compliance with Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”). 
  

	1.	Your employment with the Company will be as an employee at will. Your status as an officer of the Company will be determined by the Board of Directors of the Company in accordance
with the By-Laws of the Company. 

  

	 2.
	 Should the Company terminate your employment other than for cause (as hereinafter defined), the Company will pay to you,
subject to paragraph 6 below, on a bi-weekly basis (or other regular payroll cycle in use by the Company at the time your employment terminates), twelve (12) months of severance (the “Severance Period”), based on your then current
base salary; provided, however, that any such amount otherwise payable to you prior to sixty (60) days after such termination of employment shall be paid, subject to paragraph 6 below, on the sixtieth (60th) day following such termination of employment. In addition, your medical/prescriptions/dental/vision benefits will be continued until the end of the
Severance Period or until similar benefits become available to you from a new employer, whichever comes first. Such benefits continuation shall be on the same basis as if you had continued in the employ of the Company (e.g., including any
required associate contributions) during that period adjusted for any plan changes. The payment of severance, however, is expressly conditioned upon your compliance with the terms set forth in paragraph 4(b) of this Letter Agreement.

 The term “cause” shall mean the following: your conviction for any felony, fraud or embezzlement or crime of
moral turpitude; controlled substance abuse; alcoholism which interferes with or affects your responsibilities to the Company or which reflects negatively upon the integrity or reputation of the Company; gross negligence which is materially
injurious to the Company; any violation of any express written directions or any reasonable written policy or procedure established by the Company from time to time regarding the conduct of its business; or any violation by you of any material term
and condition of this Letter Agreement. 

	3.	Upon a reduction in your current base salary, as the same may be increased from time to time, which is not part of a general salary reduction for a majority of salaried employees of
the Company and to which you do not consent in writing, you will have the right (subject to the notice and cure provisions below) to resign and receive the severance benefits described above, with your severance payments based on your salary prior
to it having been reduced. In order to exercise this right you must have given written notice to the Company of the reduction in base salary within sixty (60) days after it is so reduced, and the Company must not have remedied the base salary
reduction within the thirty (30) day period after receipt of such written notice; provided further, however, that any termination of employment by you under this paragraph 3 must occur not later than one (1) year
following the initial existence of the base salary reduction giving rise to your right to terminate under this paragraph 3. 

  

	4.	(a) Your employment with the Company and your receipt of stock options is expressly conditioned upon your consent and agreement to be bound by the non-competition and
non-solicitation provisions set forth in Attachment A hereto, which Attachment A is made a part hereof in its entirety. 

 (b)
Further, should the Company terminate your employment other than for “cause” (as defined in paragraph 2 of this Letter Agreement) or should you terminate your employment pursuant to paragraph 3 above, you also agree that your receipt of
the severance payments and benefits provided for herein is expressly conditioned upon your consent and agreement to continue to be bound by the non-competition and non-solicitation provisions set forth in Attachment A hereto and your execution and
delivery within fifty (50) days after termination of your employment of, and your failure to revoke within the statutory revocation period, the General Release Agreement, the form of which is attached hereto as Exhibit B. 
  

	5.	This Letter Agreement may be amended only by a written instrument signed by the Company and you. Except with respect to your Change in Control Agreement with the Company, and any
other agreement between the Company and you specifically referenced herein and intended to continue beyond the execution of this Letter Agreement, this Letter Agreement shall constitute the entire agreement between the Company and you with respect
to the subject matter hereof and supersedes any other severance or separation pay plan or policy that would otherwise apply to you. This Letter Agreement shall be governed by the laws of the State of New York, without regard to the principles of
conflict of laws thereof. This Letter Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective successors, heirs (in your case) and assigns. 

  

	6.	 It is intended that this Letter Agreement will comply with Section 409A of the Code (and any regulations and guidelines issued thereunder) to the extent the
Letter Agreement is subject thereto, and the Letter Agreement shall be interpreted on a basis consistent with such intent. If an amendment of the Letter Agreement is necessary in order for it to comply with Section 409A, the parties hereto will

  

 -2- 

	 	 
negotiate in good faith to amend the Letter Agreement in a manner that preserves the original intent of the parties to the extent reasonably possible.
Notwithstanding any provision to the contrary in this Letter Agreement, if you are deemed on the date of your “separation from service” (within the meaning of Treas. Reg. Section 1.409A-1(h)) to be a “specified employee”
(within the meaning of Treas. Reg. Section 1.409A-1(i)), then with regard to any payment that is required to be delayed pursuant to Section 409A(a)(2)(B) of the Code, such payment shall not be made prior to the earlier of (i) the
expiration of the six (6)-month period measured from the date of your “separation from service,” or (ii) the date of your death (the “Delay Period”). Upon the expiration of the Delay Period, all payments delayed pursuant to
this paragraph 6 (whether they would have otherwise been payable in a single sum or in installments in the absence of such delay) shall be paid to you in a lump sum, and any remaining payments due under this Letter Agreement shall be paid in
accordance with the normal payment dates specified for them herein. Notwithstanding any provision of this Letter Agreement to the contrary, your employment will be deemed to have terminated on the date of your “separation from service”
(within the meaning of Treas. Reg. Section 1.409A-1(h)) with the Company. Wherever payments under this Letter Agreement are to be made in installments, each such installment shall be deemed to be a separate payment for purposes of
Section 409A. No action or failure to act, pursuant to this paragraph 6 shall subject the Company to any claim, liability, or expense, and the Company shall not have any obligation to indemnify or otherwise protect you from the obligation to
pay any taxes pursuant to Section 409A of the Code. 

  

			
	Sincerely,
		
	By:	 	 
		 	 Ronald A. Malone
 Chairman and Chief Executive Officer

 Agreed to and Accepted by: 
  

							
				
	  	 		 		 	  
		 		 		 	Date

  

 -3- 

 ATTACHMENT A 
 CONFIDENTIALITY AND RESTRICTIVE COVENANT AGREEMENT 
 1. Confidentiality 
 Except as may be required by the lawful order of a court or agency of competent jurisdiction, or applicable law, or except to the extent that you have
express authorization from Gentiva Health Services Inc., you agree to keep secret and confidential indefinitely all non-public information (including, without limitation, information regarding litigation and pending litigation; any information that
may be subject to attorney-client privilege; financial data, business and management information, strategies and plans and internal practices and procedures; proprietary technical information, including but not limited to, systems and equipment
information; business and management development plans) concerning Gentiva Health Services Inc., its subsidiaries and affiliates or its predecessors (collectively, the “Company”) which was acquired by or disclosed to you during the course
of your employment with the Company, and not to disclose the same, either directly or indirectly, to any other person, firm, or business entity, or to use it in any way. Such non-public information shall include, but not be limited to, any of the
following, including any compilation of any parts thereof: 
 A. information which the Company has compiled to identify, develop and service its clients and
customers, including “negative research” to identify those entities who have not subscribed to the Company’s services; 
 B. information which
the Company has compiled concerning the operations of the Company’s clients and customers, including key contacts within the clients’ and customers’ business, familiarity with special needs and customer characteristics, workers’
compensation information, billing rates, profit margins, sales volumes and other sensitive financial information; and 
 C. information which the Company has
compiled concerning the Company’s employees and labor force, including compilations of their names, addresses, job skills, employment histories and employment records. 
 Upon termination of your employment, you shall promptly deliver to the Company all materials of a confidential nature relating to the Company’s
business and which are in your possession or control. To the extent that you obtained information on behalf of the Company or any subsidiary or affiliate that may be subject to attorney-client privilege, you shall take reasonable steps to maintain
the confidentiality of such information and to preserve such privilege. 
 2. Non-Competition 
 You acknowledge that the Company conducts its business throughout the United States and the District of Columbia. You further acknowledge that your duties
to the Company related to all of these territories and to all business lines of the Company. In the event your employment with the Company terminates for any reason, you agree that for a period of twelve (12) months from the date of such
termination (“the Employment Termination Date”), and in a geographic area defined to be the United States and the District of Columbia, you shall not, directly or indirectly: 

 
(1) perform or provide any services which are similar to the duties performed by you while employed by the Company to any individual or business which is
engaged in the type of business(es) similar to the type of business(es) conducted by the Company; and/or (2) own, manage, operate, control, be employed by, participate in, provide services or financial assistance to, or be connected in any
manner with, the ownership, management, operation or control of any business which directly competes with the Company or engages in the type of business(es) principally conducted by the Company, except you may own for investment purposes only up to
1% of the capital stock of any such company whose stock is publicly traded. 
 You further acknowledge that the limitations contained in this
paragraph 2 are reasonable and do not impose any greater restraint than is necessary to protect the goodwill or other legitimate business interests of the Company. 
 3. Non-Solicitation of Employees 
 You agree that for a period of 12 months following your Employment Termination Date you
shall not directly or indirectly, solicit or induce any employee, current or future, of the Company to leave the Company for any reason whatsoever, or hire any current or future employees of the Company. 
 4. Non-Solicitation of Clients and Customers 
 You
agree that for a period of 12 months following your Employment Termination Date you shall not solicit or accept on behalf of yourself or anyone else any of the Company’s customers and/or clients with a view to sell or provide any product or
service competitive with any product or service sold or provided or under development by the Company. For the purposes of this section of Attachment A, the term “customers” and/or “client” shall include any person or entity to
whom the Company, through its offices in which you had direct or indirect oversight and managerial duties during your employment with the Company, has sold, provided or been obligated to provide, any service or product, or who has otherwise received
any service or benefit from the Company, within 24 months prior to your last day of employment with the Company (“Employment Termination Date”). If you are unsure as to whether you would be prohibited by this clause from soliciting a
particular client or customer, you should contact the Vice President of Human Resources. 
 5. Remedies 
 You acknowledge and agree that the provisions of paragraphs 1, 2, 3, 4 and 7 of this Attachment A are reasonable and necessary for the protection of the
Company and that the Company will be irreparably and irrevocably damaged if such provisions are not specifically enforced. In the event of a breach or threatened breach of the provisions of paragraphs 1, 2, 3, 4 and 7 of this Attachment A, the
Company shall be entitled to seek injunctive relief (without bond or other security being posted) as well as any and all other applicable remedies at law and in equity, including an action for damages. In addition, in the event of a breach of the
provisions of paragraphs 1, 2, 3, 4, and 7, you acknowledge that you will forfeit all options to purchase stock granted to you, vested or unvested and/or the proceeds from the sale of stock obtained from options granted to you during the term of
your employment with the Company. You agree to pay any and all reasonable attorneys’ fees incurred by the Company in successfully enforcing any covenant contained in this Agreement. 
  

 -2- 

 6. Enforcement 
 The parties hereby agree that if the scope or enforceability of any of the restrictive covenants contained in paragraphs 1, 2, 3, 4 and 7 of this Attachment A is in dispute, a court or other trier of fact should
modify and enforce the covenant in the form necessary to bring it into compliance with applicable law. 
 7. Non-Disparagement 
 You agree that you shall not make any false, defamatory or disparaging statements about the Company, its officers, directors and employees. 
 8. Violation Not a Defense. 
 You agree that the
covenants set forth in this Agreement shall accrue to the benefit of the Company, irrespective of the reason for termination of your employment with the Company. In an action by the Company to enforce this Agreement, any claims asserted by you
against the Company, including but not limited to any claim that the covenants should not be enforced because the Company terminated the employment relationship, shall not constitute a defense to any action to enforce the terms of this Agreement.

 9. Extension of Obligations. 
 If you
breach any of the provisions of paragraph 2, 3 or 4 of this Agreement, and if the Company brings legal action for injunctive relief, such relief shall have the duration specified in those paragraphs, commencing from the date such relief is granted,
but reduced by the period of time elapsed between the Employment Termination Date and your first breach of this Agreement. 
 10. Severability.

 If any provision, paragraph or subparagraph of this Agreement is adjudged by any court to be void or unenforceable in whole or in part,
this adjudication shall not affect the validity of the remainder of the Agreement, including any other provision, paragraph or subparagraph. Each provision, paragraph, and subparagraph of this Agreement is separable from every other provision,
paragraph and subparagraph and constitutes a separate and distinct covenant. 
 11. Assignment. 
 This Agreement shall be binding upon and inure to the benefit of the Company, its successors and assigns and to the benefit of you, your heirs and legal
representatives. This Agreement is not assignable by you. This Agreement may be assigned by the Company without your consent. Your transfer to any corporate parent, affiliate or subsidiary of the Company shall constitute an assignment. 

 

 -3- 

 EXHIBIT B 
 GENERAL RELEASE 
 1) I,
                    , understand that, in order to receive the severance package contained in Section 2 of the Letter Agreement between
Gentiva Health Services, Inc. and me dated as of [                    ] (the “Letter Agreement”) which I would not otherwise receive
or be entitled to, I have been requested to sign this General Release. I further understand that by signing this General Release, I am waiving my right to raise any claims against Gentiva Health Services, Inc. (“Gentiva” or “the
Company”) and other Releasees (as defined below) under federal, state and/or local law. 
 2) General Release 
 I hereby agree to release and forever discharge the Company, its subsidiaries and affiliates, and its and their directors and officers, predecessors,
employees, agents, successors and assigns (collectively “Releasees”) from any and all actions or causes of action, suits, claims, charges, complaints, contracts and promises whatsoever, in law or equity which I, my heirs, assigns and any
personal or legal representatives have or may have against any of the Releasees including all unknown, undisclosed and unanticipated losses, wrongs, injuries, debts, claims and/or damages arising out of or in any way connected with my employment
with the Company or its subsidiaries and the cessation of such employment. This shall include but not be limited to any alleged violation of Title VII of the Civil Rights Act of 1964, Section 1981 et seq. of Title 42 of the
United States Code, the Employee Retirement Income Security Act of 1974, the Americans with Disabilities Act of 1990, the Age Discrimination in Employment Act of 1967, the Fair Labor Standards Act, the Occupational, Safety and Health Act, the New
York Human Rights Law, Executive Law Section 290 et seq., the New York Labor Law, the New York Equal Rights Law Section 40 et seq., the New York Minimum Wage Law, the New York Equal Pay Law, each of the
foregoing as amended, and any and all other Federal, State or local civil or human rights laws, or any other alleged violation of any local, State or Federal law, regulation or ordinance, and/or public policy, contract or tort or common-law claim
having any bearing whatsoever on the terms and conditions and/or cessation of my employment with the Company and its subsidiaries which I now have or shall have as of the date of this General Release. 
 This General Release does not constitute a waiver of my right to bring action against the Company to enforce the terms and provisions of the Letter
Agreement. 
 This General Release does not constitute a waiver of my prior indemnification rights, if any, should I be ordered to appear as
a witness or made a defendant in any litigation regarding matters or actions taken within the scope of my responsibilities as an employee of the Company. 

 3) Not A Waiver of Vested Benefits 
 This General Release shall not constitute a waiver of (i) right to benefits which have vested on or prior to the date of termination of my employment or the terms of any applicable employee benefit plan, or
(ii) my unreimbursed business expenses properly incurred prior to the date my employment was terminated in accordance with Company policy. 
 4)
Covenant Not to Sue 
 I agree that I will not file, charge (except that I may file a charge with the Equal Employment Opportunity
Commission alleging age discrimination), claim, sue or cause or permit to be filed any civil action, suit or legal proceeding seeking personal equitable or monetary relief for me in connection with any matter occurring at any time in the past
concerning my employment relationship with the Company, up to and including the date of this General Release, or involving any continuing effects of any acts or practices which may have arisen or occurred on or prior to the date of this General
Release. I further agree that should any person, organization, or other entity file, charge, claim, sue, or cause or permit to be filed any civil action, suit or legal proceeding involving any matter occurring at any time in the past, I will not
seek or accept any personal relief in such civil action, suit or legal proceeding. Nothing in this Section 4 shall limit my right to cooperate with the Equal Employment Opportunity Commission (“EEOC”) in an investigation of a charge
of age discrimination, including a charge filed with the EEOC filed by me. 
 5) Non-Disclosure of Terms 
 I hereby agree that I shall not directly or indirectly publish the terms or conditions of this General Release nor discuss or make any statements with
regard to such terms or conditions except to my personal lawyer or as required by law. 
 6) Governing Law and Interpretation 
 This General Release shall be governed by and construed in accordance with the laws of New York State without regard to its conflict of laws provisions.
Should any provision of this General Release be declared illegal or unenforceable by any court of competent jurisdiction, and cannot be modified to be enforceable, such provision shall immediately become null and void, leaving the remainder of this
General Release in full force and effect. However, if the release portion is held invalid or unenforceable by a court of competent jurisdiction or any governmental agency, or I exercise my right to rescind set forth in Section 8 below, then I
agree to immediately return to the Company any payment I received as part of the severance package and the Company shall have no further obligation under the Letter Agreement. 
 7) Entire Agreement; Amendment 
 This General Release and the Letter Agreement, along with Attachment
A, set forth the entire agreement between the parties hereto and shall supersede any and all prior understandings between the parties, except to the extent as set forth in the Letter Agreement. This General Release may not be amended except by a
written agreement signed by both parties to the Letter Agreement. 
  

 -2- 

 8) Effective Date; Right to Revoke 
 I understand that I have been provided the opportunity to review this General Release for a period of twenty-one (21) days. I understand that this General Release shall not become effective or enforceable until
the expiration of seven (7) days following the date on which I first execute this General Release. I also understand that I have the right to revoke this General Release within seven (7) days of when I sign this General Release and that
such revocation shall not be effective unless each of the following conditions has been met: 
 (a) the revocation is made in
writing addressed to the Company and includes the statement, “I hereby revoke my agreement to the General Release and the terms and conditions set forth in the Letter Agreement.” 
 (b) such written revocation is delivered either by hand to the office of the General Counsel of Gentiva Health Services, Inc. or by mail
with a postmark dated before the end of the seven (7) day revocation period, such mail to be certified, return receipt requested. 
 I HAVE READ AND
CONSIDERED THE TERMS AND CONDITIONS CONTAINED IN THIS GENERAL RELEASE. I UNDERSTAND THAT MY RIGHT TO RECEIVE THE SEVERANCE PACKAGE IN ACCORDANCE WITH THE LETTER AGREEMENT IS SUBJECT TO THE TERMS AND CONDITIONS SET FORTH IN THIS GENERAL RELEASE AND
THAT I WOULD NOT RECEIVE SUCH BENEFIT BUT FOR MY EXECUTION OF THIS GENERAL RELEASE. I ALSO UNDERSTAND THAT BY EXECUTING THIS GENERAL RELEASE, I WILL BE WAIVING MY RIGHTS UNDER FEDERAL, STATE AND LOCAL LAW TO BRING ANY CLAIMS THAT I HAVE OR MIGHT
HAVE AGAINST ANY RELEASEES (AS DEFINED ABOVE). I HAVE BEEN AFFORDED AT LEAST TWENTY-ONE (21) DAYS TO CONSIDER THIS GENERAL RELEASE AND HAVE BEEN ADVISED IN WRITING TO CONSULT WITH AN ATTORNEY PRIOR TO EXECUTING THIS GENERAL RELEASE. 

IN WITNESS WHEREOF, I have executed this General Release as of the date set forth below. 
  

	
	 Signed:
                                        
                

	
	 Date:
                                        
    

  

 -3-

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00138-of-00352.parquet"}]]